Showing results (1481-1490 of 1,651) with videos related to
Sort By:
Pageof 166
Plos Pathogens|January 29, 2026
The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsidJun Hong, Akshay Deshpande, Yatish Thakare, et al.FEBS Letters|July 31, 2021
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in miceRalf Salzer, Jordan J Clark, Marina Vaysburd, et al.Journal of Medicinal Chemistry|March 1, 1996
Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of actionM Evers, C Poujade, F Soler, et al.Developmental Cell|October 20, 2020
Functional Diversification of SRSF Protein Kinase to Control Ubiquitin-Dependent Neurodevelopmental SignalingFrancisco Bustos, Anna Segarra-Fas, Gino Nardocci, et al.The Journal of Biological Chemistry|January 1, 2016
Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIα by Lysine AcetylationNora Kuhlmann, Sarah Wroblowski, Philipp Knyphausen, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Whole body MondoA deletion protects against diet-induced obesity through uncontrolled multi-organ substrate utilization and futile cyclingJustin H Berger, Allison N Lau, Larry C James, et al.Neurotrauma Reports|April 24, 2024
The Australian Traumatic Brain Injury Initiative: Review and Recommendations for Outcome Measures for Use With Adults and Children After Moderate-to-Severe Traumatic Brain InjuryJennie L Ponsford, Amelia J Hicks, Matthew K Bagg, et al.Plos Pathogens|March 23, 2011
HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2Karen E Ocwieja, Troy L Brady, Keshet Ronen, et al.Lancet (London, England)|October 3, 1981
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantationJ R Hobbs, K Hugh-Jones, A J Barrett, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccinationMaria Bottermann, Stian Foss, Laurens M van Tienen, et al.Pageof 166